Toggle Health Problems and D

COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D) - Jan 2022

Characteristics of COVID-19 in patients with multiple sclerosis - Jan 2022

Multiple Sclerosis and Related Disorders 57 (2022) 103437 - Authors from Iran https://doi.org/10.1016/j.msard.2021.103437

Study obeserved, but did not comment on the fact that
   85% of MSers were taking Vitamin D


Background: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study
Multiple rclercste of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.

Methods: Data on MS patients with COVID-19 from nine provinces of Iran were entered in a web-based registry system, between July 2020 and March 2021. Among the COVID-19 symptoms, dyspnea, altered mental status, or those resulting in hospital admission were considered severe.

Results: A total of 397 eligible patients were identified. In addition, 310 (78%) were female. The mean age was 36.5 ± 9.5. 294 (74%) patients had relapsing- remitting form. Also, four patients (1%) expired due to COVID-19 infection. The mean duration of admission in hospitalized patients was 9 (± 5.3) days. MRI was performed on 111 (28%) patients after developing COVID-19. MRI changes were observed in 27 (24%) of these cases. MS drug was changed in 26 (6%) patients. Steroid use in the past three months (OR: 2.43, 95% CI: 1.003-5.88) (p value: 0.049) and antiCD20s (OR: 4.03, 95% CI: 2.41-6.68) (p value < 0.001) showed significant association with severe COVID-19 symptoms.

Conclusion: The death rate of COVID-19 among MS patients (1%) is lower than the overall death rate of the pandemic in Iran (3%). Those who received steroid in the past three months may be at increased risk of more severe forms of COVID-19. There are still doubts about the effect of anti CD20s on COVID-19 severity.
 Download the PDF from VitaminDWiki

VitaminDWiki - Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D) – April 30, 2021

VitaminDWiki - MS updates from Brazil

VitaminDWiki - Multiple Sclerosis 32 percent less likely among those with more than 32 ng of vitamin D – Dec 2019 contains

UV and Sunshine reduces MS risk

Other things also help

High Dose Vitamin D and cofactors

Number of MS studies which are also in other categories

  • 20 studies in Genetics - genes can restrict Vitamin D getting to the blood and to the cells
  • 11 studies in Vitamin D Receptor - gene which restricts D from getting to the cells
  • 7 studies in Vitamin D Binding Protein - gene which restricts D from getting to the cells
  • 20 studies in Ultraviolet light - may be even better than Vitamin D in preventing and treating MS
  • 9 studies in Omega-3 - which helps Vitamin D prevent and treat MS

Created by admin. Last Modification: Wednesday January 12, 2022 15:22:26 GMT-0000 by admin. (Version 10)

Attached files

ID Name Comment Uploaded Size Downloads
16878 MS COVID.jpg admin 12 Jan, 2022 13:06 23.17 Kb 177
16877 COVID MS.pdf PDF 2021 admin 12 Jan, 2022 13:05 353.75 Kb 135
See any problem with this page? Report it (WORKS NOV 2021)